Research Presentation Sessions: Chest

RPS 1504 - Imaging of the airways and ILDs

Lectures

1
Evaluation of quantitative airway-artery dimensions and ratios of normal CT scans: a study from birth to adulthood

Evaluation of quantitative airway-artery dimensions and ratios of normal CT scans: a study from birth to adulthood

07:00Qianting Lv, Rotterdam / NL

2
Small airways disease and emphysema in pre-COPD: a cross-sectional study

Small airways disease and emphysema in pre-COPD: a cross-sectional study

07:00Stijn Verleden, Edegem / BE

3
Interstitial lung abnormalities in low-dose CT screening population: risk factors for the development of clinically significant interstitial lung disease

Interstitial lung abnormalities in low-dose CT screening population: risk factors for the development of clinically significant interstitial lung disease

07:00Wonjong Jeong, Seoul / KR

4
General population bronchial parameters: results from the ImaLife study

General population bronchial parameters: results from the ImaLife study

07:00Ivan Dudurych, Groningen / NL

5
AI-based small pulmonary artery and vein quantification are associated with lung function impairment in Chronic Obstructive Pulmonary Disease

AI-based small pulmonary artery and vein quantification are associated with lung function impairment in Chronic Obstructive Pulmonary Disease

07:00Anastasia K.A.L. Kwee, Utrecht / NL

6
The effect of SilverBeam filter on cyst scores in patients with cystic lung diseases

The effect of SilverBeam filter on cyst scores in patients with cystic lung diseases

07:00Chloe Steveson, Adelaide / AU

7
Quantitative computed tomography assessment of interstitial lung disease associated with connective tissue disease

Quantitative computed tomography assessment of interstitial lung disease associated with connective tissue disease

07:00Honghong Guo, Lan Zhou / CN

8
Prognostic implications of clinical imaging and blood biomarkers on progression in fibrotic interstitial lung diseases using quantitative CT analysis

Prognostic implications of clinical imaging and blood biomarkers on progression in fibrotic interstitial lung diseases using quantitative CT analysis

07:00Johannes Wasmayr, Linz / AT

9
Minimal clinically important difference (MCID) for quantitative analysis of progressive pulmonary fibrosis on high-resolution computed tomography (HRCT)

Minimal clinically important difference (MCID) for quantitative analysis of progressive pulmonary fibrosis on high-resolution computed tomography (HRCT)

07:00Ludovica Iaccarino, Rome / IT

10
Are pre-existing interstitial lung abnormalities (ILAs) a risk factor for the development of fibrotic changes during follow-up of Covid-19 patients?

Are pre-existing interstitial lung abnormalities (ILAs) a risk factor for the development of fibrotic changes during follow-up of Covid-19 patients?

07:00Davide Colombi, Piacenza / IT

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.